Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
X4 Pharmaceuticals, Inc. (XFOR) had Debt to Capital Ratio of 0.77 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$28.81M |
|
$0.28M |
|
$4.72M |
|
$24.09M |
|
$38.25M |
|
$-9.44M |
|
$9.76M |
|
$0.32M |
|
$0.32M |
|
$0.28M |
|
$0.28M |
|
$0.28M |
|
$0.28M |
|
$-9.44M |
|
$-8.97M |
|
6.84M |
|
6.87M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$95.70M |
|
$0.49M |
|
$34.32M |
|
$130.01M |
|
$25.88M |
|
$75.63M |
|
$81.19M |
|
$107.07M |
|
$22.94M |
|
$-4.22M |
|
$22.94M |
|
5.79M |
|
| Cash Flow Statement Financials | |
$-12.37M |
|
$-3.14M |
|
-- |
|
$56.48M |
|
$41.04M |
|
$-15.43M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.70 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.77 |
3.30 |
|
83.63% |
|
-32.78% |
|
-32.78% |
|
-- |
|
1.10% |
|
0.98% |
|
$-12.37M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
1.53 |
|
24.54 |
|
3.67 |
|
1.23% |
|
-6.68% |
|
0.22% |
|
0.29% |
|
$3.96 |
|
$-1.80 |
|
$-1.80 |
|